Home » Topics » BioWorld Science, Cancer

BioWorld Science, Cancer
RSS

Kyowa Hakko reports antitumor antibiotic UCH15B at Japanese meeting

April 16, 1998

Antitumor illudin analogues discovered at U. of California

April 16, 1998

AnorMED licenses platinum anticancer agent to Zeneca

April 15, 1998

Water-soluble taxane derivatives under evaluation at Yakult Honsha

April 15, 1998

MMP inhibitors particularly active against MMP-13 described by Monsanto

April 15, 1998

Structure and biological activity of UCH9, a novel antitumor antibiotic

April 15, 1998

Antitumor combretastatin A4 derivative reported by Ajinomoto

April 14, 1998

Antiangiogenic ribozyme from Ribozyme and Chiron presented at cancer meeting

April 14, 1998

New bFGF-TK inhibitor from Parke-Davis

April 14, 1998

Taisho's rugatocenones inhibit cell adhesion

April 14, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 24, 2026.
Detecting the invisible: minimal residual disease at AACR 2026
BioWorld Science
Minimal residual disease (MRD) has become a central concept in modern oncology, reshaping how clinicians evaluate response, relapse risk and treatment precision....
A free gene therapy? Regeneron’s Otarmeni approved for hearing loss
BioWorld
Children and adults with a type of congenital hearing loss now have a free treatment option, with the U.S. FDA’s accelerated approval of Regeneron Pharmaceuticals...
AACR 2026: The age of agentic AI in oncology
BioWorld Science
New Approach Methodologies (NAMs) for drug development are transforming biomedical research by replacing or complementing animal models. More than 90% of...
In the clinic for April 21, 2026
BioWorld
Clinical updates for biopharma and med tech, including data readouts and publications: Abbott, Agenus, Astrazeneca, Briacell, Clearmind, Greenwich, Intodna,...